Now showing items 1-10 of 420
Glucagon-like peptide-1 receptor agonists and heart failure in type 2 diabetes: systematic review and meta-analysis of randomized and observational studies
(BioMed Central, 2016)
BACKGROUND: The effect of glucagon-like peptide-1(GLP-1) receptor agonists on heart failure remains uncertain. We therefore conducted a systematic review to assess the possible impact of GLP-1 agonists on heart failure or ...
Depressive symptoms in the family caregivers of patients with heart failure: an integrative review
(Escola de Enfermagem da UFRGS, 2019)
Changes in echocardiographic parameters in iron deficiency patients with heart failure and chronic kidney disease treated with intravenous iron
(Elsevier Inc, 2015-07)
BACKGROUND: Treatment of iron deficiency helps to improve cardiac and renal function in patients with chronic heart failure. However, the mechanism by which this occurs is currently unclear. METHODS: We undertook a ...
Vascular parameters for ambulatory monitoring of congestive heart failure patients: proof of concept
Purpose: Prompt detection of congestion is an essential target in order to prevent heart failure (HF) related hospitalization, being ambulatory monitoring a promising strategy to do so. A successful non-invasive ambulatory ...
Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies
(BMJ Publishing Group, 2016)
OBJECTIVES: To examine the association between dipeptidyl peptidase-4 (DPP-4) inhibitors and the risk of heart failure or hospital admission for heart failure in patients with type 2 diabetes. DESIGN: Systematic review ...
Telehealth in Heart Failure Care during COVID-19 Pandemic Lockdown in Argentina
(Korean Society of Heart Failure, 2020-12)
Background and Objectives: During the coronavirus disease 2019 (COVID-19) pandemic, virtual visits (VVs) were recommended as an innovative and necessary alternative for patients with heart failure (HF). To assess the ...
SGLT-2 inhibitors for people with type 2 diabetes.
Evidence that sodium-glucose co-transporter-2 inhibitors (SGLT2i) can reduce cardiovascular risk—with trials showing reductions in cardiovascular death, myocardial infarction, and stroke—would suggest they have much to ...
Implications of endothelium dysfunction in heart failureImplicaciones del endotelio en la insuficiencia cardiaca
(Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana, 2014)